108 related articles for article (PubMed ID: 16579694)
21. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation.
Teramura Y; Iwata H
Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458
[TBL] [Abstract][Full Text] [Related]
22. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T
Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218
[TBL] [Abstract][Full Text] [Related]
23. Microfluidics-generated pancreatic islet microfibers for enhanced immunoprotection.
Jun Y; Kim MJ; Hwang YH; Jeon EA; Kang AR; Lee SH; Lee DY
Biomaterials; 2013 Nov; 34(33):8122-30. PubMed ID: 23927952
[TBL] [Abstract][Full Text] [Related]
24. The influence of immune system stimulation on encapsulated islet graft survival.
Orłowski TM; Godlewska E; Tarchalska M; Kinasiewicz J; Antosiak M; Sabat M
Arch Immunol Ther Exp (Warsz); 2005; 53(2):180-4. PubMed ID: 15928588
[TBL] [Abstract][Full Text] [Related]
25. A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem Cells.
Hirabaru M; Kuroki T; Adachi T; Kitasato A; Ono S; Tanaka T; Matsushima H; Sakai Y; Soyama A; Hidaka M; Yamanouchi K; Takatsuki M; Okano T; Eguchi S
Tissue Eng Part C Methods; 2015 Dec; 21(12):1205-15. PubMed ID: 26066973
[TBL] [Abstract][Full Text] [Related]
26. Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats.
Balamurugan AN; Nelson EJ; Ramakrishna B; Gunasekaran S
Xenotransplantation; 2007 Jul; 14(4):316-22. PubMed ID: 17669173
[TBL] [Abstract][Full Text] [Related]
27. Beta-cell sparing in transplanted islets by vascular endothelial growth factor.
Stagner J; Mokshagundam S; Wyler K; Samols E; Rilo H; Stagner M; Parthasarathy L; Parthasarathy R
Transplant Proc; 2004 May; 36(4):1178-80. PubMed ID: 15194408
[TBL] [Abstract][Full Text] [Related]
28. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets.
Contreras JL; Xie D; Mays J; Smyth CA; Eckstein C; Rahemtulla FG; Young CJ; Anthony Thompson J; Bilbao G; Curiel DT; Eckhoff DE
Surgery; 2004 Sep; 136(3):537-47. PubMed ID: 15349100
[TBL] [Abstract][Full Text] [Related]
29. Molecularly engineered islet cell clusters for diabetes mellitus treatment.
Yook S; Jeong JH; Jung YS; Hong SW; Im BH; Seo JW; Park JB; Lee M; Ahn CH; Lee H; Lee DY; Byun Y
Cell Transplant; 2012; 21(8):1775-89. PubMed ID: 22613624
[TBL] [Abstract][Full Text] [Related]
30. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets.
Jang JY; Lee DY; Park SJ; Byun Y
Biomaterials; 2004 Aug; 25(17):3663-9. PubMed ID: 15020141
[TBL] [Abstract][Full Text] [Related]
31. Survival and function of transplanted islet cells on an in vivo, vascularized tissue engineering platform in the rat: A pilot study.
Brown DL; Meagher PJ; Knight KR; Keramidaris E; Romeo-Meeuw R; Penington AJ; Morrison WA
Cell Transplant; 2006; 15(4):319-24. PubMed ID: 16898225
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
[TBL] [Abstract][Full Text] [Related]
33. Immunoisolation of pancreatic islets via thin-layer surface modification.
Pathak S; Pham TT; Jeong JH; Byun Y
J Control Release; 2019 Jul; 305():176-193. PubMed ID: 31029742
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging monitoring of poly(ethylene glycol) conjugated islets for evaluation of islet graft rejection.
Jeong JH
Arch Pharm Res; 2015; 38(5):785-90. PubMed ID: 24862650
[TBL] [Abstract][Full Text] [Related]
35. Immobilization of soluble complement receptor 1 on islets.
Luan NM; Teramura Y; Iwata H
Biomaterials; 2011 Jul; 32(20):4539-45. PubMed ID: 21459435
[TBL] [Abstract][Full Text] [Related]
36. Tolerance of islet allografts induced by orthotopic liver transplantation.
Sawada T; Asanuma Y; Furuya T; Saito K; Koyama K
J Surg Res; 1999 Aug; 85(2):209-16. PubMed ID: 10423321
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.
Lopez-Talavera JC; Garcia-Ocaña A; Sipula I; Takane KK; Cozar-Castellano I; Stewart AF
Endocrinology; 2004 Feb; 145(2):467-74. PubMed ID: 14551233
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of sertoli-islet cell aggregates formed by microgravity: prolonged survival in diabetic rats.
Han X; Qiu L; Zhang Y; Kong Q; Wang H; Wang H; Li H; Duan C; Wang Y; Song Y; Wang C
Exp Biol Med (Maywood); 2009 May; 234(5):595-603. PubMed ID: 19244542
[TBL] [Abstract][Full Text] [Related]
39. Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model.
Jung YS; Jeong JH; Yook S; Im BH; Seo J; Hong SW; Park JB; Yang VC; Lee DY; Byun Y
Biomaterials; 2012 Jan; 33(1):295-303. PubMed ID: 21982296
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 modulation in pancreatic islets using a cell-permeable A-box fragment.
Hwang YH; Kim MJ; Lee YK; Lee M; Lee DY
J Control Release; 2017 Jan; 246():155-163. PubMed ID: 28038946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
